Radiology Information Systems Market Report: Industry Insights and Competitive Landscape

The global radiology information systems market was valued at USD 1.2 billion in 2025 and is expected to grow from USD 1.3 billion in 2026 to USD 2.6 billion by 2033, registering a CAGR of 10.5% during the forecast period from 2026 to 2033. North America accounted for the largest revenue share of 40.0% in 2025. Market growth is being driven by increasing investments in healthcare IT infrastructure, supportive government initiatives promoting digital healthcare solutions, and the growing adoption of radiology information systems across hospitals and diagnostic centers. The rising demand for cloud-based platforms and integrated imaging solutions is further accelerating market expansion.

The radiology information systems (RIS) market is witnessing significant growth as healthcare providers continue to modernize imaging workflows and improve operational efficiency. The increasing prevalence of chronic diseases, including cancer, cardiovascular disorders, osteoporosis, chronic obstructive pulmonary disease (COPD), and arthritis, has led to higher demand for diagnostic imaging services. As imaging volumes continue to rise, healthcare organizations are adopting advanced RIS solutions to streamline patient scheduling, image tracking, reporting, billing, and data management. The growing integration of RIS with picture archiving and communication systems (PACS), electronic health records (EHRs), and artificial intelligence-powered imaging tools is enhancing clinical decision-making, improving workflow automation, and enabling seamless information sharing across healthcare facilities.

Key Market Trends & Insights

• By end use: Hospitals & clinics segment held the largest market share of 81.2% in 2025.
• By deployment mode: Cloud-based segment held the largest market share of 78.4% in 2025.
• By product: Integrated RIS segment held the largest market share of 67.7% in 2025.

Regional Highlights

• Largest regional market: North America (40.0% revenue share, 2025)
• Fastest-growing regional market: Asia Pacific (highest CAGR, 2026–2033)
• By country: The U.S. held the largest market share in 2025.

Market Size & Forecast

• Market size in 2025: USD 1.2 Billion
• Estimated market size in 2026: USD 1.3 Billion
• Projected market size by 2033: USD 2.6 Billion
• CAGR (2026–2033): 10.5%

Download a free sample copy of the Radiology Information Systems Market report to access detailed market intelligence, segment-wise analysis, competitive benchmarking, and long-term industry forecasts.

Key Market Participants Insights

Leading companies in the radiology information systems market are focusing on product innovation, cloud-based platform development, strategic partnerships, and AI integration to strengthen their market position. Vendors are enhancing interoperability with electronic health records, PACS, and hospital information systems while investing in workflow automation and advanced analytics to improve diagnostic efficiency and patient care. These initiatives are helping healthcare organizations optimize radiology operations and support the growing demand for digital imaging solutions.

Key Radiology Information Systems Companies

The following key companies have been profiled for this study on the radiology information systems market.

• DeepHealth
• Epic Systems Corporation
• GE Healthcare
• Merative
• Koninklijke Philips N.V.
• McKesson Corporation
• MedInformatix, Inc.
• Oracle
• Pro Medicus, Ltd.
• Siemens Healthineers AG
• Veradigm LLC

Recent Developments

• In June 2025, Soliton IT partnered with xWave to enhance radiology workflows across the NHS by integrating xWave's AI-powered clinical decision support technology into the Radiology+ RIS platform. The combined solution automates referral assessment, identifies incomplete or low-priority imaging requests, streamlines diagnostic workflows, reduces administrative burden, and improves reporting efficiency while supporting better patient outcomes without disrupting existing healthcare infrastructure.
• In April 2025, Konica Minolta introduced the next-generation Exa Platform featuring an upgraded Exa PACS|RIS solution with enhanced API capabilities for third-party integrations and native Exa Advanced Imaging functionality. The new platform is designed to improve interoperability, simplify imaging workflows, and provide healthcare providers with greater flexibility in managing radiology operations.

Explore Grand View Horizon to see global and regional level statistics related to the Radiology Information Systems Market

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments.
• Extended forecast timelines for long-term planning.
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments.
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making
• And much more…

Looking for a report customized to your requirements? Explore our Custom Research Offering

Small Molecule API CDMO Market: Growth Opportunities for Pharmaceutical Companies

The global small molecule API CDMO market was valued at USD 46.6 billion in 2025 and is expected to grow from USD 49.4 billion in 2026 to USD 80.7 billion by 2033, registering a CAGR of 7.3% during the forecast period from 2026 to 2033. North America accounted for the largest market share of 40.8% in 2025. Market growth is being driven by the increasing demand for complex active pharmaceutical ingredients (APIs), expanding outsourcing activities by pharmaceutical companies, advancements in manufacturing technologies, greater emphasis on supply chain resilience, rising adoption of green chemistry practices, and the integration of digital technologies and artificial intelligence into pharmaceutical manufacturing.

The small molecule API CDMO industry is experiencing sustained expansion as pharmaceutical and biotechnology companies increasingly rely on contract development and manufacturing organizations to accelerate drug development while optimizing production costs. The growing pipeline of high-potency APIs (HPAPIs), oncology therapeutics, and structurally complex drug molecules has created strong demand for CDMOs with specialized expertise in process development, containment systems, and regulatory-compliant manufacturing. As modern drug candidates require sophisticated synthesis techniques, including multi-step chemical processes and chiral chemistry, companies are seeking integrated partners capable of supporting projects from early-stage research through commercial-scale production. Continuous investments in advanced manufacturing infrastructure, automation, and regulatory compliance are further strengthening the market's long-term growth potential.

Key Market Trends & Insights

• By end use: Pharmaceutical segment held the largest market share of 91.7% in 2025.
• By application: Oncology segment held the largest market share of 42.5% in 2025.
• By drug: Innovators segment held the largest market share in 2025.

Regional Highlights

• Largest regional market: North America (40.8% revenue share, 2025)
• Fastest-growing regional market: Asia Pacific (highest CAGR, 2026–2033)
• By country: The U.S. held the largest market share in 2025.

Market Size & Forecast

• Market size in 2025: USD 46.6 Billion
• Estimated market size in 2026: USD 49.4 Billion
• Projected market size by 2033: USD 80.7 Billion
• CAGR (2026–2033): 7.3%

Download a free sample copy of the Small Molecule API CDMO Market report to access detailed market intelligence, segment-wise analysis, competitive benchmarking, and long-term industry forecasts.

Key Market Participants Insights

The small molecule API CDMO market is highly competitive, with leading global companies expanding manufacturing capabilities, investing in high-potency API production, and strengthening integrated development services to meet growing customer demand. Major CDMOs are enhancing their expertise in complex chemistry, regulatory compliance, and commercial-scale manufacturing while forming strategic collaborations with pharmaceutical and biotechnology companies. At the same time, regional manufacturers, particularly in Asia, continue to strengthen their market position by offering cost-effective manufacturing solutions and specialized API production capabilities.

Key Small Molecule API CDMO Companies

The following key companies have been profiled for this study on the small molecule API CDMO market.

• Lonza Group
• Catalent
• Thermo Fisher Scientific
• WuXi AppTec
• Siegfried Holding AG
• Cambrex Corporation
• Recipharm
• CordenPharma
• Ajinomoto Bio-Pharma Services
• Curia
• Piramal Pharma Solutions
• Jubilant Biosys
• Syngene International
• Neuland Laboratories
• Axplora

Recent Developments

• In March 2026, Wilmington PharmaTech expanded its USD 50 million manufacturing facility in Delaware, doubling its U.S. API production capacity. The expansion enhances domestic pharmaceutical supply chains, strengthens high-potency API manufacturing capabilities, and improves the company's ability to support scalable small molecule production.
• In October 2025, Cambrex announced a USD 120 million investment to expand its Charles City, Iowa manufacturing facility by approximately 40%. The project is aimed at increasing API and peptide manufacturing capacity while supporting greater supply chain resilience for pharmaceutical customers.
• In July 2025, Radyus Research (U.S.) and Eurofins CDMO Alphora (Canada) entered into a strategic partnership to provide integrated early-stage drug development and GMP manufacturing services for small molecule APIs. The collaboration enables streamlined support from preclinical development through clinical proof-of-concept, helping global biotechnology companies accelerate drug development timelines.

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments.
• Extended forecast timelines for long-term planning.
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments.
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making
• And much more…

Looking for a report customized to your requirements? Explore our Custom Research Offering

How Pet Humanization Is Reshaping the Pet Supplements Market

The global pet supplements market size was valued at USD 2.8 billion in 2025 and is projected to grow from USD 2.9 billion in 2026 to USD 4.6 billion by 2033, at a CAGR of 6.9% from 2026 to 2033. The market in North America dominated with a revenue share of 48.1% in 2025. The rising demand for the pet supplements market can be attributed to the rise in pet humanization, which has led to consumers spending significantly on pet food, supplements, and other related products to keep them active and healthy.

Supplements enhance concentration, focus, and energy levels in pets, strengthen their immune system, and improve heart health. Anti-stress, anti-anxiety, or calming supplements are also witnessing a high demand and are anticipated to gain further traction among pet owners. The pet supplements market is witnessing strong growth as pet ownership increases and pets are increasingly treated as integral members of the family. This “pet humanization” trend has fundamentally changed purchasing behavior, with pet parents prioritizing preventive healthcare, long-term wellness, and quality of life for their animals. Supplements are no longer viewed as occasional add-ons but as part of routine pet care, particularly for managing nutrition gaps, age-related conditions, and behavioral health concerns.

Key Market Trends & Insights

• By type: Over-the-counter (OTC) segment held the largest market share of 86.5% in 2025.
• By distribution channel: Offline segment held the largest market share of 76.5% in 2025.
• By form: Chewables segment held the largest market share of 69.8% in 2025.
• By pet type: Dogs segment held the largest market share of 63.1% in 2025.
• By application: Hip & joint segment held the largest market share of 21.6% in 2025.

Regional Highlights

• Largest regional market: North America (48.1% revenue share, 2025)
• Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)
• By country: The U.S. held the largest market share in 2025

Market Size & Forecast

• Market size in 2025: USD 2.8 Billion
• Estimated market size in 2026: USD 2.9 Billion
• Projected market size by 2033: USD 4.6 Billion
• CAGR (2026-2033): 6.9%

Download a free sample copy of the Pet Supplements Market report to gain detailed market insights, comprehensive segmentation analysis, competitive benchmarking, and future growth projections.

Key Market Participants Insights

The following key companies have been profiled for this study on the pet supplements market.

• Nestlé
• FOODSCIENCE
• Ark Naturals
• NOW Foods
• Virbac
• Zoetis
• Bayer AG
• Pet Honesty
• Nutramax Laboratories
• Zesty Paws

Recent Developments

• In January 2026, Zesty Paws launched Zesty Paws Professional, its first vet-exclusive line, entering the veterinary channel with two science-driven canine supplements: Native Canine Probiotic for fast-acting digestive and diarrhea support using canine-native strains, and Healthy Aging NAD+ Precursor (with Niagen) to help maintain cellular energy, metabolism, and overall vitality in aging dogs, distributed through epiq Animal Health and Durvet and available from January 2026 as a complement to its existing retail portfolio.
• In February 2025, Elanco Animal Health launched Pet Protect, a new line of veterinarian-formulated, science-backed supplements for dogs and cats aimed at supporting everyday wellness needs such as skin health, stress, joints, and immune function, expanding its over-the-counter pet health portfolio in the rapidly growing U.S. pet supplement market, which reached about $2.7 billion in 2023 with strong sustained growth.

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments.
• Extended forecast timelines for long-term planning.
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments.
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making
• And much more…

Looking for a report customized to your requirements? Explore our Custom Research Offering

Medical Tourism Market Share, Industry Trends & Growth Analysis

The global medical tourism market was valued at USD 34.0 billion in 2025 and is anticipated to grow from USD 38.6 billion in 2026 to USD 126.2 billion by 2035, registering a CAGR of 14.1% during the forecast period from 2026 to 2035. Turkey emerged as the leading destination, accounting for a 13.5% revenue share in 2025. Market growth is primarily fueled by affordable treatment costs, access to advanced medical technologies, high-quality healthcare services, modern medical infrastructure, innovative therapies, exceptional hospitality, and personalized patient care.

The medical tourism industry is witnessing robust expansion as patients increasingly travel abroad to receive high-quality healthcare at competitive prices. Rising healthcare expenses and long waiting times in developed countries are encouraging individuals to seek treatment in international destinations that offer cost-effective and timely medical services. In addition, growing demand for elective procedures that are often excluded from insurance coverage—including cosmetic surgery, fertility treatments, gender reassignment procedures, and complex dental care—is significantly contributing to market growth. Improvements in healthcare infrastructure, international hospital accreditations, telemedicine support, and government initiatives promoting medical tourism are further strengthening the industry's growth prospects.

Key Market Trends & Insights

• By service provider: Private segment held the largest market share of 54.8% in 2025.
• By treatment type: Cosmetic segment held the largest market share of 24.2% in 2025.

Regional Highlights

• Largest country: Turkey (13.5% revenue share, 2025)

Market Size & Forecast

• Market size in 2025: USD 34.0 Billion
• Estimated market size in 2026: USD 38.6 Billion
• Projected market size by 2035: USD 126.2 Billion
• CAGR (2026–2035): 14.1%

Download a free sample copy of the Medical Tourism Market report to gain detailed market insights, comprehensive segmentation analysis, competitive benchmarking, and future growth projections.

Key Market Participants Insights

Leading organizations in the medical tourism market are focusing on strategic collaborations, service expansion, international partnerships, and infrastructure development to strengthen their global presence and attract a larger international patient base. Healthcare providers are also investing in advanced medical technologies, specialized treatment centers, and integrated patient support services to enhance the overall treatment experience and improve competitiveness in the global medical tourism landscape.

Key Medical Tourism Companies

The following key companies have been profiled for this study on the medical tourism market.

• MOHW Hengchun Tourism Hospital
• Apollo Hospitals Enterprise Ltd.
• Bumrungrad International Hospital
• Mount Elizabeth Hospitals
• Raffles Medical Group
• Dr. B. L. Kapur Memorial Hospital
• Kasemrad Hospital International Rattanathibet
• Mission Hospital
• Bangkok Hospital
• Miot Hospital
• Penang Adventist Hospital

Recent Developments

• In June 2025, MIOT Hospital introduced the Tibia Nail Advanced System for the treatment of tibial fractures, marking the first deployment of this technology in India. Developed by AO-Synthes, Switzerland, the system features Angle-Stable technology, which improves implant stability and supports faster patient recovery, strengthening the hospital's advanced orthopedic care capabilities.
• In March 2025, Shanghai Renji Hospital and Singapore's Raffles Medical Group entered into a strategic collaboration to establish a "dual circulation" medical resource service system. The partnership aims to enhance cross-border healthcare services, support China's Healthy China 2035 Plan, and strengthen Shanghai's position as a leading international medical tourism destination.
• In January 2024, Ferns N Petals launched MediJourney, a dedicated medical tourism platform offering comprehensive healthcare solutions across more than 30 treatment specialties, including cardiology, oncology, and other advanced medical services. The initiative is designed to simplify medical travel while improving access to quality healthcare and patient support services.

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments.
• Extended forecast timelines for long-term planning.
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments.
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making
• And much more…

Looking for a report customized to your requirements? Explore our Custom Research Offering

Global Enzymes Market Growth, Trends & Forecast Report

The global enzymes market was valued at USD 14.9 billion in 2025 and is expected to increase from USD 15.8 billion in 2026 to USD 25.1 billion by 2033, registering a CAGR of 6.9% during the forecast period from 2026 to 2033. North America accounted for the largest market share of 36.3% in 2025. Market expansion is supported by increasing enzyme utilization in food manufacturing, pharmaceutical production, and biofuel development, along with the growing emphasis on environmentally sustainable industrial operations. Technological progress in enzyme engineering and rising applications in animal nutrition and diagnostic solutions are further contributing to industry growth.

The enzymes market continues to expand as industries increasingly adopt enzyme-based solutions to improve production efficiency and sustainability. Enzymes are gaining widespread acceptance as effective biocatalysts that lower energy requirements and reduce reliance on harsh chemicals in manufacturing. Consumer preference for natural ingredients and clean-label food products is encouraging greater use of enzyme formulations in the food and beverage sector. In livestock nutrition, enzymes improve feed efficiency, support animal well-being, and help minimize environmental emissions. Furthermore, ongoing investments in biotechnology, protein engineering, and recombinant DNA techniques are enhancing enzyme performance and enabling cost-effective large-scale manufacturing.

Key Market Trends & Insights

• By source: Microorganisms segment held the largest market share of 85.8% in 2025.
• By type: Industrial enzymes segment held the largest market share of 56.5% in 2025.
• By product: Carbohydrase segment held the largest market share of 47.9% in 2025.

Regional Highlights

• Largest regional market: North America (36.3% revenue share, 2025)
• Fastest-growing regional market: Asia Pacific (highest CAGR, 2026–2033)
• By country: The U.S. held the largest market share in 2025.

Market Size & Forecast

• Market size in 2025: USD 14.9 Billion
• Estimated market size in 2026: USD 15.8 Billion
• Projected market size by 2033: USD 25.1 Billion
• CAGR (2026–2033): 6.9%

Download a free sample copy of the Enzymes Market report to explore comprehensive market analysis, detailed segmentation, competitive landscape, and research scope.

Key Market Participants Insights

Leading companies in the enzymes market are implementing strategic initiatives such as product innovation, partnerships, acquisitions, and capacity expansion to strengthen their competitive position and broaden their global presence. These initiatives are helping companies address the growing demand for enzyme-based solutions across diverse industries. Prominent participants in the market include Novonesis, International Flavors & Fragrances (IFF), DSM, and several other global manufacturers.

• Novonesis is a leading biotechnology company specializing in industrial enzymes and microbial solutions for a broad range of commercial applications. The company develops advanced enzyme technologies to improve efficiency across industries including food processing, household care, animal nutrition, agriculture, and renewable fuels. Operating in more than 30 countries, Novonesis serves customers across over 40 industrial sectors through manufacturing facilities located in Denmark, Brazil, Argentina, China, Canada, the United States, and India.
• DSM is an innovation-focused global company providing solutions in health, nutrition, and sustainable living. Its business portfolio spans food and beverages, animal nutrition, healthcare, renewable energy, personal care, coatings, and advanced materials. Through its Nutrition segment, DSM develops and supplies enzymes designed for multiple industrial and nutritional applications. The company serves customers in over 50 countries while continuing to invest in research, product innovation, and sustainable technologies.

Key Enzymes Companies

The following key companies have been profiled for this study on the enzymes market:

• BASF
• Novonesis
• International Flavors & Fragrances (IFF)
• DSM
• Novus International, Inc.
• Associated British Foods plc
• Kerry
• Advanced Enzyme Technologies
• Amano Enzyme Inc.
• Adisseo

Recent Developments

• In January 2024, Novozymes and Chr. Hansen completed their merger to establish Novonesis, creating one of the world's largest biosolutions companies. The merger combines the strengths of both organizations to accelerate innovation in sustainable biotechnology and expand enzyme-based solutions across multiple industries. This strategic integration enhances product offerings, global manufacturing capabilities, and research expertise, reinforcing growth within both industrial and specialty enzyme markets.
• In March 2025, IFF and Kemira announced the launch of Alpha Bio, a joint venture dedicated to expanding the production of sustainable bio-based materials through enzyme-enabled technologies. The collaboration focuses on replacing fossil-derived polymers with biodegradable alternatives produced from plant-based sugars. This initiative supports the growing demand for environmentally friendly, high-performance materials while highlighting the expanding role of enzymes in green chemistry and industrial biotechnology.

Explore Grand View Horizon to see global and regional level statistics related to the Enzymes Market

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments.
• Extended forecast timelines for long-term planning.
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments.
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making
• And much more…

Looking for a report customized to your requirements? Explore our Custom Research Offering